Page last updated: 2024-08-17

allyl isothiocyanate and Peripheral Nerve Diseases

allyl isothiocyanate has been researched along with Peripheral Nerve Diseases in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Baraldi, PG; Geppetti, P; Materazzi, S; Preti, D1
Kase, Y; Kono, T; Miyagi, C; Miyano, K; Mizuno, K; Omiya, Y; Suzuki, Y; Uezono, Y1

Reviews

1 review(s) available for allyl isothiocyanate and Peripheral Nerve Diseases

ArticleYear
Transient receptor potential ankyrin 1 (TRPA1) channel as emerging target for novel analgesics and anti-inflammatory agents.
    Journal of medicinal chemistry, 2010, Jul-22, Volume: 53, Issue:14

    Topics: Analgesics; Animals; Anti-Inflammatory Agents; Asthma; Humans; Ion Channel Gating; Neurons; Pain; Peripheral Nervous System Diseases; Pulmonary Disease, Chronic Obstructive; Transient Receptor Potential Channels

2010

Other Studies

1 other study(ies) available for allyl isothiocyanate and Peripheral Nerve Diseases

ArticleYear
Goshajinkigan, a traditional Japanese medicine, prevents oxaliplatin-induced acute peripheral neuropathy by suppressing functional alteration of TRP channels in rat.
    Journal of pharmacological sciences, 2014, Volume: 125, Issue:1

    Topics: Acute Disease; Animals; Cold Temperature; Disease Models, Animal; Drugs, Chinese Herbal; Ganglia, Spinal; Gene Expression; Isothiocyanates; Male; Menthol; Nociception; Organoplatinum Compounds; Oxaliplatin; Peripheral Nervous System Diseases; Phytotherapy; Rats; Rats, Sprague-Dawley; RNA, Messenger; Transient Receptor Potential Channels; TRPA1 Cation Channel; TRPC Cation Channels; TRPM Cation Channels

2014